Friday, January 11, 2008

First Quick MRSA Test Approved

Filed under: Critical Care , Medicine , Surgery

The FDA just gave approval to the first quick test for drug resistant staph infections, known as MRSA. The product is made by Becton, Dickinson and Co. of Franklin Lake, NJ.

The BD GeneOhm StaphSR Assay uses molecular methods to identify whether a blood sample contains genetic material from the MRSA bacterium or the more common, less dangerous staph bacterium that can still be treated with methicillin.

"The BD GeneOhm test is good news for the public health community. Rather than waiting more than two days for test results, health care personnel will be able to identify the source of a staph infection in only two hours, allowing for more effective diagnosis and treatment," said Daniel G. Schultz, M.D., director, FDA's Center for Devices and Radiological Health.

Here's the product brochure:

FDA press release: FDA Clears First Quick Test For Drug-Resistant Staph Infections

Product page: BD GeneOhm™ MRSA Assay

email this article to a friend      print this!           comments and peer reviews (0)






replies: 0 comments
Open comments are not moderated, although abusive and vulgar remarks may be deleted. Opinions expressed do not necessarily reflect the views of Medgadget.com. Please consult our disclaimer.

add a comment
html tags: <b>, <i>, and <a>
examples: <b>Bold</b> <i>Italic</i>









Remember personal info?
(anonymous comments allowed)



click to make your selection boldclick to make your selection italicclick to add a link


Verification (needed to reduce spam):




Click the "Post" button only once!